🍽️ dibucaine,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Local Anesthesia: Dibucaine belongs to the class of medications known as local anesthetics, which work by blocking nerve signals in a specific area of the body, leading to temporary loss of sensation or pain relief. Dibucaine is used to provide local anesthesia for minor surgical procedures, dental procedures, and medical interventions involving the skin, mucous membranes, or other superficial tissues.

  2. Topical Application: Dibucaine is most commonly administered topically as a cream, ointment, gel, or solution that is applied directly to the skin or mucous membranes to numb the area before a procedure or to relieve pain or itching associated with minor skin conditions such as insect bites, minor burns, cuts, abrasions, or hemorrhoids.

  3. Analgesic Effects: Dibucaine provides temporary pain relief by blocking the transmission of pain signals from sensory nerves to the brain. It can help alleviate discomfort and pain associated with minor injuries, skin irritations, or medical procedures, allowing patients to undergo treatment or perform activities with greater comfort.

  4. Anti-Itch Properties: In addition to its analgesic effects, dibucaine has mild anti-itch properties that can help relieve itching and irritation associated with insect bites, allergic reactions, dermatitis, or other inflammatory skin conditions. Dibucaine may be used alone or in combination with other medications to provide relief from itching and discomfort.

  5. Onset and Duration of Action: Dibucaine typically has a rapid onset of action, with numbing effects occurring within minutes after application to the skin or mucous membranes. The duration of action varies depending on factors such as the concentration of dibucaine, the site of application, and individual patient factors, but generally lasts for several hours before wearing off.

  6. Side Effects: While generally safe when used as directed, dibucaine can cause local side effects such as skin irritation, redness, swelling, or allergic reactions in some individuals. Prolonged or excessive use of dibucaine or application to large areas of the body may increase the risk of systemic side effects such as systemic toxicity or allergic dermatitis.

  7. Contraindications: Dibucaine is contraindicated in individuals with a known hypersensitivity or allergy to the medication or any of its components. It should not be applied to broken or inflamed skin, mucous membranes, or areas with impaired barrier function, as this may increase the risk of systemic absorption and adverse effects.

  8. Interactions: Dibucaine may interact with other medications or substances, including other local anesthetics, that affect the nervous system or cardiovascular function. It's important for individuals using dibucaine to inform their healthcare provider about all other medications, supplements, or topical products they are using to avoid potential interactions or adverse effects.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of dibucaine,(prescription) On Probiotics

Rank Probiotic Impact
species Bacteroides uniformis Reduces
species Escherichia coli Reduces
species Lacticaseibacillus paracasei Reduces
species Parabacteroides distasonis Reduces

Bacteria Impacted by dibucaine,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Morganellaceae family Decreases 👪 Source Study
Escherichia genus Decreases 👪 Source Study
Roseburia genus Decreases 👪 Source Study
Proteus genus Decreases 📓 Source Study Opportunistic urinary tract infections
Parabacteroides genus Decreases 👪 Source Study BMI, fat percent,blood pressure
Bacteroides genus Decreases 👪 Source Study
Bilophila genus Decreases 👪 Source Study High Level Cause Brain Fog(Cognitive impairment)
Fusobacterium genus Decreases 👪 Source Study Periodontal disease, Lemierre syndrome, skin ulcers
Lacrimispora genus Decreases 👪 Source Study
Leishmania genus Decreases 👪 Source Study
Phocaeicola genus Decreases 👪 Source Study
Lacticaseibacillus genus Decreases 👪 Source Study
Escherichia coli O25:H16 no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
Escherichia coli O145:H34 no rank Decreases 👶 Source Study
Escherichia coli O16:H48 no rank Decreases 👶 Source Study
unclassified Proteus (in: enterobacteria) no rank Decreases 👶 Source Study
Escherichia coli O141:H4 no rank Decreases 👶 Source Study
Escherichia coli O139:H1 no rank Decreases 👶 Source Study
Escherichia coli O80:H26 no rank Decreases 👶 Source Study
Escherichia coli O158:H23 no rank Decreases 👶 Source Study
Escherichia coli O84:H7 no rank Decreases 👶 Source Study
Escherichia coli O2:K1:H4 no rank Decreases 👶 Source Study
Escherichia coli O2:K1:H7 no rank Decreases 👶 Source Study
Escherichia coli O78:H51 no rank Decreases 👶 Source Study
Escherichia coli O18ac:H14 no rank Decreases 👶 Source Study
Escherichia coli O85:H1 no rank Decreases 👶 Source Study
Escherichia coli O7:H15 no rank Decreases 👶 Source Study
Escherichia coli O68:H12 no rank Decreases 👶 Source Study
Escherichia coli O55:H7 no rank Decreases 👶 Source Study
Escherichia coli O1:K1:H7 no rank Decreases 👶 Source Study
Escherichia coli O15:H12 no rank Decreases 👶 Source Study
Escherichia coli O170:H18 no rank Decreases 👶 Source Study
Escherichia coli O155:H21 no rank Decreases 👶 Source Study
Escherichia coli O19:H7 no rank Decreases 👶 Source Study
Escherichia coli O2:K1:H5 no rank Decreases 👶 Source Study
Escherichia coli O20:H12 no rank Decreases 👶 Source Study
Escherichia coli O111 serogroup Decreases 👶 Source Study
Escherichia coli O121 serogroup Decreases 👶 Source Study
Escherichia coli O155 serogroup Decreases 👶 Source Study
Escherichia coli O177 serogroup Decreases 👶 Source Study
Escherichia coli O26 serogroup Decreases 👶 Source Study
Escherichia coli O3 serogroup Decreases 👶 Source Study
Escherichia coli O5 serogroup Decreases 👶 Source Study
Escherichia coli O86 serogroup Decreases 👶 Source Study
Escherichia coli O91 serogroup Decreases 👶 Source Study
Escherichia coli O103 serogroup Decreases 👶 Source Study
Escherichia coli O78 serogroup Decreases 👶 Source Study
Escherichia coli O43 serogroup Decreases 👶 Source Study
Escherichia coli O119 serogroup Decreases 👶 Source Study
Escherichia coli O157 serogroup Decreases 👶 Source Study
Escherichia coli O145 serogroup Decreases 👶 Source Study
Escherichia coli O1:HNT serotype Decreases 👶 Source Study
Escherichia coli O10:K5(L):H4 serotype Decreases 👶 Source Study
Escherichia coli O103:H11 serotype Decreases 👶 Source Study
Escherichia coli O103:H25 serotype Decreases 👶 Source Study
Escherichia coli O104:H21 serotype Decreases 👶 Source Study
Escherichia coli O111:H11 serotype Decreases 👶 Source Study
Escherichia coli O111:H8 serotype Decreases 👶 Source Study
Escherichia coli O112ac:H19 serotype Decreases 👶 Source Study
Escherichia coli O114:H49 serotype Decreases 👶 Source Study
Escherichia coli O118:H16 serotype Decreases 👶 Source Study
Escherichia coli O121:H7 serotype Decreases 👶 Source Study
Escherichia coli O123:H11 serotype Decreases 👶 Source Study
Escherichia coli O127:H27 serotype Decreases 👶 Source Study
Escherichia coli O127:H6 serotype Decreases 👶 Source Study
Escherichia coli O128:H2 serotype Decreases 👶 Source Study
Escherichia coli O128ac:H12 serotype Decreases 👶 Source Study
Escherichia coli O145:H25 serotype Decreases 👶 Source Study
Escherichia coli O145:NM serotype Decreases 👶 Source Study
Escherichia coli O146:H21 serotype Decreases 👶 Source Study
Escherichia coli O153:H2 serotype Decreases 👶 Source Study
Escherichia coli O156:H25 serotype Decreases 👶 Source Study
Escherichia coli O157:H43 serotype Decreases 👶 Source Study
Escherichia coli O157:NM serotype Decreases 👶 Source Study
Escherichia coli O165:H25 serotype Decreases 👶 Source Study
Escherichia coli O174:H2 serotype Decreases 👶 Source Study
Escherichia coli O174:H21 serotype Decreases 👶 Source Study
Escherichia coli O174:H8 serotype Decreases 👶 Source Study
Escherichia coli O176:H45 serotype Decreases 👶 Source Study
Escherichia coli O177:NM serotype Decreases 👶 Source Study
Escherichia coli O26:H1 serotype Decreases 👶 Source Study
Escherichia coli O28ac:NM serotype Decreases 👶 Source Study
Escherichia coli O29:H4 serotype Decreases 👶 Source Study
Escherichia coli O32:H37 serotype Decreases 👶 Source Study
Escherichia coli O6:H16:CFA/II serotype Decreases 👶 Source Study
Escherichia coli O69:H11 serotype Decreases 👶 Source Study
Escherichia coli O78:H12 serotype Decreases 👶 Source Study
Escherichia coli O79:H7 serotype Decreases 👶 Source Study
Escherichia coli O81:NM serotype Decreases 👶 Source Study
Escherichia coli O86:H34 serotype Decreases 👶 Source Study
Escherichia coli O91:H14 serotype Decreases 👶 Source Study
Escherichia coli O91:NM serotype Decreases 👶 Source Study
Escherichia coli ONT:H33 serotype Decreases 👶 Source Study
Escherichia coli O100:H21 serotype Decreases 👶 Source Study
Escherichia coli O121:H19 serotype Decreases 👶 Source Study
Escherichia coli O157:H7 serotype Decreases 👶 Source Study bloody diarrhea
Escherichia coli O16:H6 serotype Decreases 👶 Source Study
Escherichia coli O89m:H9 serotype Decreases 👶 Source Study
Escherichia coli O111:H- serotype Decreases 👶 Source Study
Escherichia coli O113:H21 serotype Decreases 👶 Source Study
Escherichia coli H20 serotype Decreases 👶 Source Study
Escherichia coli O150:H6 serotype Decreases 👶 Source Study
Escherichia coli O111:NM serotype Decreases 👶 Source Study
Escherichia coli O112ab:H8 serotype Decreases 👶 Source Study
Escherichia coli O99:H6 serotype Decreases 👶 Source Study
Escherichia coli O26:H11 serotype Decreases 👶 Source Study
Escherichia coli O145:H28 serotype Decreases 👶 Source Study
Escherichia coli O126:H45 serotype Decreases 👶 Source Study
Escherichia coli O2:H6 serotype Decreases 👶 Source Study
Escherichia coli O7:H4 serotype Decreases 👶 Source Study
Escherichia coli O1:H42 serotype Decreases 👶 Source Study
Escherichia coli O25:NM serotype Decreases 👶 Source Study
Escherichia coli O25:H1 serotype Decreases 👶 Source Study
Escherichia coli O7:K1 serotype Decreases 👶 Source Study
Escherichia coli O125ac:K+:H10 serotype Decreases 👶 Source Study
Escherichia coli O6:K2:H1 serotype Decreases 👶 Source Study
Escherichia coli O152:H23 serotype Decreases 👶 Source Study
Escherichia coli O15:H18 serotype Decreases 👶 Source Study
Escherichia coli O39:NM serotype Decreases 👶 Source Study
Escherichia coli O44:H18 serotype Decreases 👶 Source Study
Escherichia coli O2:K2:H1 serotype Decreases 👶 Source Study
Escherichia coli O8:H8 serotype Decreases 👶 Source Study
Escherichia coli O89m:H10 serotype Decreases 👶 Source Study
Escherichia coli O10:H32 serotype Decreases 👶 Source Study
Escherichia coli O6:H16 serotype Decreases 👶 Source Study
Escherichia coli O157:H- serotype Decreases 👶 Source Study
Escherichia coli O45:H2 serotype Decreases 👶 Source Study
Escherichia coli O103:H2 serotype Decreases 👶 Source Study
Escherichia coli O167:H26 serotype Decreases 👶 Source Study
Escherichia coli O104:H4 serotype Decreases 👶 Source Study
Escherichia coli O83:H1 serotype Decreases 👶 Source Study
Escherichia coli O9:H10 serotype Decreases 👶 Source Study
Escherichia coli O78:H4 serotype Decreases 👶 Source Study
Escherichia coli O139:H28 serotype Decreases 👶 Source Study
Parabacteroides distasonis species Decreases 📓 Source Study
Parabacteroides merdae species Decreases 📓 Source Study Infectious bacteria
Proteus mirabilis species Decreases 👶 Source Study
Escherichia coli species Decreases 📓 Source Study Diarrheal disease in children and travelers, Foodborne diarrhea outbreaks, hemorrhagic colitis, hemolytic-uremic syndrome
Proteus genomosp. 6 species Decreases 👶 Source Study
Proteus hauseri species Decreases 👶 Source Study
Proteus myxofaciens species Decreases 👶 Source Study
Lacrimispora saccharolytica species Decreases 📓 Source Study
Bacteroides fragilis species Decreases 📓 Source Study H02076 Bacteroides infection
Phocaeicola vulgatus species Decreases 📓 Source Study
Roseburia intestinalis species Decreases 📓 Source Study
Proteus vulgaris species Decreases 👶 Source Study
Bacteroides uniformis species Decreases 📓 Source Study Infectious bacteria
Fusobacterium nucleatum species Decreases 📓 Source Study Infectious bacteria
Bilophila wadsworthia species Decreases 📓 Source Study
Proteus terrae species Decreases 👶 Source Study
Lacticaseibacillus paracasei species Decreases 📓 Source Study
Proteus columbae species Decreases 👶 Source Study
Proteus penneri species Decreases 👶 Source Study
Leishmania donovani species complex species group Decreases 👶 Source Study
Leishmania major species complex species group Decreases 👶 Source Study
Leishmania mexicana species complex species group Decreases 👶 Source Study
Leishmania subgenus Decreases 📓 Source Study
Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases 👶 Source Study
Fusobacterium nucleatum subsp. nucleatum subspecies Decreases 👶 Source Study
Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases 👶 Source Study

Impact of dibucaine,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.3 0.3
ADHD 1.4 1.4
Age-Related Macular Degeneration and Glaucoma 0.5 0.4 0.25
Allergic Rhinitis (Hay Fever) 1.3 0.4 2.25
Allergies 2 0.6 2.33
Allergy to milk products 0.7 1.3 -0.86
Alopecia (Hair Loss) 1.1 1.1
Alzheimer's disease 2.4 2 0.2
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.8 0.4 1
Ankylosing spondylitis 1.9 0.6 2.17
Anorexia Nervosa 0.4 1.1 -1.75
Antiphospholipid syndrome (APS) 0.6 0.3 1
Asthma 1.8 0.8 1.25
Atherosclerosis 2.2 0.8 1.75
Atrial fibrillation 1 1.6 -0.6
Autism 2.7 4.5 -0.67
Autoimmune Disease 0.6 0.5 0.2
Barrett esophagus cancer 0.3 0.3
benign prostatic hyperplasia 0.6 0.3 1
Biofilm 1 1
Bipolar Disorder 1.6 0.5 2.2
Brain Trauma 0.5 0.8 -0.6
Breast Cancer 0.5 0.5
Cancer (General) 0.3 0 0
Carcinoma 2 0.7 1.86
Celiac Disease 1.4 1 0.4
Cerebral Palsy 0.3 0.8 -1.67
Chronic Fatigue Syndrome 1.1 1.8 -0.64
Chronic Kidney Disease 1.3 0.8 0.63
Chronic Lyme 0.8 -0.8
Chronic Obstructive Pulmonary Disease (COPD) 0.7 0.8 -0.14
Chronic Urticaria (Hives) 1 0.3 2.33
Coagulation / Micro clot triggering bacteria 1.4 0.5 1.8
Cognitive Function 0.7 0.5 0.4
Colorectal Cancer 3.4 1.5 1.27
Constipation 1.1 0.5 1.2
Coronary artery disease 1 1.1 -0.1
COVID-19 2.9 1.5 0.93
Crohn's Disease 4.7 1.8 1.61
Cushing's Syndrome (hypercortisolism) 0.5 -0.5
cystic fibrosis 1 0.8 0.25
d-lactic acidosis (one form of brain fog) 0.4 0.4
deep vein thrombosis 1.8 0.8 1.25
Denture Wearers Oral Shifts 0.1 0.1
Depression 4.1 2.7 0.52
Eczema 0.9 0.3 2
Endometriosis 1.7 0.9 0.89
Eosinophilic Esophagitis 0.3 0.3
Epilepsy 1.8 1.3 0.38
erectile dysfunction 1.2 1.2
Fibromyalgia 1.6 0.4 3
Functional constipation / chronic idiopathic constipation 2.5 1.5 0.67
gallstone disease (gsd) 2.2 0.8 1.75
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.9 0.9
Generalized anxiety disorder 1.6 0.3 4.33
Gout 0.3 0.3
Graves' disease 0.7 0.8 -0.14
Gulf War Syndrome 0.3 -0.3
Halitosis 0.7 0.7
Hashimoto's thyroiditis 1.4 0.6 1.33
Heart Failure 1.8 0.5 2.6
hemorrhagic stroke 0.7 0.7
Hidradenitis Suppurativa 1.4 1.4
High Histamine/low DAO 2.2 2.2
hypercholesterolemia (High Cholesterol) 0.4 0.4
hyperglycemia 1 0.7 0.43
Hyperlipidemia (High Blood Fats) 0.3 0.3
hypersomnia 0.3 -0.3
hypertension (High Blood Pressure 1.9 1.4 0.36
Hypothyroidism 0.5 0.5
Hypoxia 1.7 1.7
IgA nephropathy (IgAN) 1 0.7 0.43
Inflammatory Bowel Disease 3.1 2.7 0.15
Insomnia 0.3 0.8 -1.67
Intelligence 0.8 0.8
Intracranial aneurysms 1 1
Irritable Bowel Syndrome 2.7 1.6 0.69
ischemic stroke 1.1 1.4 -0.27
Liver Cirrhosis 3.1 1.8 0.72
Long COVID 2.4 1.8 0.33
Low bone mineral density 0.5 -0.5
Lung Cancer 0.9 0.9
Lymphoma 0.6 0.6
Mast Cell Issues / mastitis 0.7 0.7
ME/CFS with IBS 0.3 -0.3
ME/CFS without IBS 0.9 -0.9
Menopause 0.5 -0.5
Metabolic Syndrome 3.1 2.5 0.24
Mood Disorders 3.4 2.5 0.36
Multiple Sclerosis 2.4 2.1 0.14
myasthenia gravis 0.6 0.5 0.2
neuropathic pain 1.3 -1.3
Neuropathy (all types) 1.6 -1.6
neuropsychiatric disorders (PANDAS, PANS) 0.4 0.4
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 2.1 1.3 0.62
NonCeliac Gluten Sensitivity 0.3 0.3 0
Obesity 3.3 2 0.65
obsessive-compulsive disorder 2.3 0.3 6.67
Osteoarthritis 1 0.3 2.33
Osteoporosis 1.4 0.3 3.67
pancreatic cancer 0.1 0.1
Parkinson's Disease 3.8 2.5 0.52
Polycystic ovary syndrome 3.8 1.1 2.45
Premenstrual dysphoric disorder 0.4 -0.4
primary biliary cholangitis 0.4 -0.4
Primary sclerosing cholangitis 1.5 1 0.5
Psoriasis 0.6 1.9 -2.17
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 3.3 1.4 1.36
Rosacea 0.5 -0.5
Schizophrenia 1.4 1.3 0.08
scoliosis 0.9 0.3 2
sensorineural hearing loss 0.5 0.5
Sjögren syndrome 1 0.8 0.25
Sleep Apnea 0.3 0.8 -1.67
Slow gastric motility / Gastroparesis 0.7 0.7
Small Intestinal Bacterial Overgrowth (SIBO) 1.5 1.5
Stress / posttraumatic stress disorder 1.9 1.3 0.46
Systemic Lupus Erythematosus 2.1 0.8 1.63
Tic Disorder 0.3 0.3
Tourette syndrome 0.3 -0.3
Type 1 Diabetes 1.7 1.1 0.55
Type 2 Diabetes 3.6 2.6 0.38
Ulcerative colitis 2.9 2.2 0.32
Unhealthy Ageing 1.5 1 0.5
Vitiligo 1 0.4 1.5

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]